Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

Non-obstructive Azoospermia Clinical Trial

Official title: The Use of Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery

Status Completed

Clinical Trial Summary

The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.

Clinical Trial Description

This is a double-blinded, placebo-controlled, randomized trial that will recruit patients categorized into two study arms. Patients in the gabapentin arm will receive gabapentin 600mg taken pre-operatively and 300mg taken three times a day for 3 days, while patients in the placebo arm will receive a placebo drug taken pre-operatively three times a day for 3 days. ;

Related Conditions & MeSH terms

• Azoospermia
• Non-obstructive Azoospermia
• Pain, Postoperative

• NCT number: NCT04230980
• Study type: Interventional
• Source: Weill Medical College of Cornell University
• Status: Completed
• Phase: Phase 3
• Start date: July 28, 2020
• Completion date: December 16, 2022